Prostate Cell News Volume 7.10 | Mar 18 2016

    0
    35
    Prostate Cell News 7.10 March 18, 2016

    Prostate Cell News

         In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  PCN on Twitter

     
    TOP STORY
    Integrative Analyses Reveal a Long Noncoding RNA-Mediated Sponge Regulatory Network in Prostate Cancer
    Researchers identified a long noncoding RNA (lncRNA)-mediated sponge regulatory network that affects the expression of many protein-coding prostate cancer driver genes, by integrating analysis of sequence features and gene expression profiles of both lncRNAs and protein-coding genes in tumors. [Nat Commun] Full Article
    Learn More: Standardized Tools for Cancer Research

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    LABORATORY RESEARCH

    An Epigenetic Reprogramming Strategy to Re-Sensitize Radioresistant Prostate Cancer Cells
    Investigators showed that irradiating prostate cancer cells stimulates a durable upregulation of stem cell markers that epigenetically reprogram these cells. [Cancer Res] Abstract

    C/EBPβ Regulates Sensitivity to Bortezomib in Prostate Cancer Cells by Inducing REDD1 and Autophagosome-Lysosome Fusion
    Researchers investigated whether C/EBPβ, a transcription factor involved in the control of autophagic gene expression, regulates resistance to proteasome inhibition. [Cancer Lett] Abstract

    Prostate-Derived Ets Factor Represses Tumorigenesis and Modulates Epithelial-to-Mesenchymal Transition in Bladder Carcinoma Cells
    In a comparison between normal urothelium and bladder tumor tissue, the authors identified significant decreases of prostate-derived Ets (E-twenty six) factor (PDEF) in the tumor tissue. The immunohistochemistry assays indicated a significantly higher immunostaining of PDEF in low-grade bladder tumors. [Cancer Lett] Abstract

    Graviola Inhibits Hypoxia-Induced NADPH Oxidase Activity in Prostate Cancer Cells Reducing Their Proliferation and Clonogenicity
    Scientists report that NADPH oxidase (NOX) expression is directly associated with prostate cancer (PCa) progression in TRAMP mice, suggesting NOX as a potential chemoprevention target in controlling PCa. [Sci Rep] Full Article

    Novel Roles for Class II Phosphoinositide 3-Kinase C2β in Signaling Pathways Involved in Prostate Cancer Cell Invasion
    Researchers showed that phosphoinositide 3-kinases-class II subfamily regulates mitogen-activated protein kinase kinase and extracellular signal-regulated kinase activation in prostate cancer cells. [Sci Rep] Full Article

    12-HETER1/GPR31, a High-Affinity 12(S)-Hydroxyeicosatetraenoic Acid Receptor, Is Significantly Up-Regulated in Prostate Cancer and Plays a Critical Role in Prostate Cancer Progression
    Researchers have determined the distribution of 12-HETER1/GPR31 in prostate cancer tissue and its role in prostate tumorigenesis using in vitro and in vivo assays. [FASEB J] Abstract

    Phosphatase of Regenerating Liver 3 (PRL-3) Is Overexpressed in Human Prostate Cancer Tissue and Promotes Growth and Migration
    The authors investigated the expression of PRL-3 mRNA in fresh-frozen samples from patients undergoing radical prostatectomy because of prostate cancer and the biological function of PRL-3 in prostate cancer cells. [J Transl Med] Full Article

    CLINICAL RESEARCH

    Pre-Diagnostic Circulating Sex Hormone Levels and Risk of Prostate Cancer by ERG Tumour Protein Expression
    The authors examined associations between pre-diagnostic circulating levels of total testosterone, free testosterone, DHT, androstanediol glucuronide, estradiol, and SHBG and risk of prostate cancer by TMPRSS2:ERG status. [Br J Cancer] Abstract

    [Free Webinar] A Guide To Successful Flow Cytometry Analysis of ALDHbr Cells - Watch Now.

     
    REVIEWS
    Dissecting the Role of microRNAs in Prostate Cancer Metastasis: Implications for the Design of Novel Therapeutic Approaches
    The authors present a comprehensive overview of the data generated in experimental tumor models indicating that specific miRNAs may impinge on the different stages of prostate cancer metastasis, including the regulation of epithelial-to-mesenchymal transition and cell migration/invasion, the interplay between cancer cells and the surrounding stroma, the control of angiogenesis, the regulation of anoikis, and the colonization of distant organs. [Cell Mol Life Sci] Abstract

    Visit our reviews page to see a complete list of reviews in the prostate cell research field.

     
    SCIENCE NEWS
    GenomeDx’s Decipher GRID and Decipher Biopsy to be Featured at the 31st Annual EAU Congress
    GenomeDx Biosciences announced that three abstracts featuring Decipher GRID (Genomics Resource Information Database) and Decipher Prostate Cancer Classifier tests will be presented. [Press release from GenomeDx Biosciences discussing research to be presented at the 31st Annual EAU Congress (EAU16), Munich] Press Release

    From our sponsor:
    Want to learn more about ALDH in breast cancer treatment response?
    Listen to the podcast.

     
    INDUSTRY NEWS
    UCLA Sells Royalty Rights Connected with Cancer Drug to Royalty Pharma
    UCLA and Royalty Pharma announced that UCLA has sold its royalty interest connected with a leading prostate cancer medication, Xtandi, whose development was based on discoveries by campus researchers. [Royalty Pharma] Press Release

    MedCom GmbH and Hitachi Medical Systems Europe Announce an Agreement to Distribute BiopSee®
    MedCom GmbH and Hitachi Medical Systems announce an agreement to distribute through Hitachi’s subsidiaries sales network in Europe BiopSee®, MedCom’s fusion imaging system for stereotactic, navigated, targeted prostate biopsy & therapy guidance, for use in conjunction with Hitachi ultrasound systems. [Hitachi Medical Systems] Press Release

     
    POLICY NEWS
    ProMark® Prostate Cancer Prognostic now included in NCCN Guidelines
    Metamark Genetics, Inc. announced that ProMark®, the first and only protein-based prognostic test for early-stage prostate cancer, has been included in the 2016 National Comprehensive Cancer Network Clinical Practice Guidelines. [Metamark Genetics, Inc.] Editorial

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Cell Signaling in Cancer: From Mechanisms to Therapy
    June 5-10, 2016
    Snowmass Village, United States

    Visit our events page to see a complete list of events in the prostate cell community.

     
    JOB OPPORTUNITIES
    NEW Clinical Research Fellow – Prostate Cancer Vaccine (University of Oxford)

    NEW Lead Scientist – Prostate Cancer (Memorial Sloan Kettering Cancer Center)

    NEW Postdoctoral Fellowship – Castration Resistant Prostate Cancer (University of Florida)

    Postdoctoral Fellowship – Optical Imaging of Prostate Cancer (CEA Tech)

    PhD Studentship – Wnt Signaling in Stem Cells and Cancer (German Cancer Research Center)

    PhD Studentship – Genome Sequencing Technologies in Prostate Cancer (University of East Anglia)

    PhD Studentship – Aggressive Prostate Cancer (University of East Anglia)

    Postdoctoral Fellowship – Prostate and Breast Cancer Molecular Mechanisms (Feinberg School of Medicine)

    Tenure Track Faculty Positions – Various Methods in Cancer Biology (Paul L. Foster School of Medicine)

    Postdoctoral Fellowship – Epidemiology of Prostate Cancer (Fred Hutchinson Cancer Research Center)

    Research Group Leader – Stress Regulated Processes During Oncogenesis (INSERM)

    Postdoctoral Fellowship – Cancer Epigenomics (Princess Margaret Cancer Centre)

    Postdoctoral Fellowship – Prostate Cancer Biology (Medical University of South Carolina )

    Postdoctoral Fellowship – Prostate Cancer and Cancer Metabolism (Cleveland Clinic)

    Post-Doc Fellowship – Metastasis of Cancer (University of Arizona Cancer Center)

    Postdoctoral Research Fellow – Cell Cycle Control and Tumorigenesis (Fred Hutchinson Cancer Research Center)

    Division Head – Medical Oncology (Fred Hutchinson Cancer Research Center)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Prostate Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Prostate Cell News: Archives | Events | Contact Us